Teva and Sanofi Mid-Stage Data Reveal Shows Best-in-Class Potential for IBD Drug

The Teva Pharmaceuticals and Sanofi drug, duvakitug, showed statistically significant and clinically meaningful results in a Phase 2b study in ulcerative colitis and Crohn’s disease. The drug is part of an emerging class of therapies that target TL1A, a protein involved in signaling that drives inflammation. The post Teva and Sanofi Mid-Stage Data Reveal Shows…

UK government denies rift with Mauritian PM over Chagos Islands deal

Downing Street says ‘details’ being discussed after newly elected Navinchandra Ramgoolam criticised the agreement Downing Street has denied that a deal with Mauritius to hand over control of the Chagos Islands is in peril after the new Mauritian prime minister said the arrangement as it stood was not beneficial to his country. The agreement, under…

Gallagher names CEOs for crisis management and financial lines

Bassett and Brookes promoted within broker’s specialty unit       Related Stories Daily Digest: Re/insurers face new age of political risk, Axis inks legacy deal, New York passes parametric law New York passes new law on parametric insurance Beazley promotes Lezzi to group head of cyber risks